SUSAN RIVERA: Open Payments
NPI 1114918786 · DUNEDIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 57 payments from 15 companies in 2025. Trend: 2023 $1,276 · 2024 $1,370 · 2025 $1,587
Food & beverage: $1,587
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $443 |
| Amgen Inc. | 13 | $305 |
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| PFIZER INC. | 7 | $142 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Lilly USA, LLC | 5 | $111 |
| Boston Scientific Corporation | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Exact Sciences Corporation | 2 | $38 |
| ConvaTec Inc. | 1 | $25 |
Products named: Ozempic, Wegovy, BREZTRI, VOQUEZNA, OTEZLA, REPATHA, AIRSUPRA, Rybelsus.
Industry payments across FL — which companies pay providers there.
